Study of PEG-Filstim sub-acute toxicity
Journal Title: Фармацевтичний журнал - Year 2017, Vol 2, Issue 2
Abstract
Febrile neutropenia caused by cytostatic therapy in the treatment of oncological diseases is a frequent complication, which results in enforced reduction in chemotherapy doses and lower effectiveness of the treatment. Introduction of the recombinant forms of the natural protein granulocyte colony-stimulating factor into clinical practice has allowed to minimize the negative consequences of myelosuppressive therapies. The main task of repeated dose toxicity studies of drugs is evaluation of damaging effects of the pharmacological substance, revealing the most sensitive organs and systems in the body. Therefore, our work was aimed at studying sub-acute toxicity of PEG-Filstim. Toxicity study of PEG-Filstim was performed in 50 white wild-type rats of both sexes with body weight 170 to 230 g on daily (28 days) subcutaneous administration in the doses of 0.5, 1.0 and 2.0 mg/kg. During the whole observational period, survival, water and food consumption, body weight and symptoms of intoxication were registered. After completion of the experiment, spontaneous diurnal diuresis was evaluated and clinical blood and urine examination performed in all groups of animals. The results have shown that PEG-Filstim on daily subcutaneous administration in the doses of 0.5, 1.0 and 2.0 mg/kg during 28 days does not cause death in the animals, nor general toxic effects on health, behaviour, food and water consumption, body weight growth in laboratory rats. Upon repeated administration in the studied doses, PEG-Filstim does not affect protein, lipid, carbohydrate metabolism, does not impair functions of urinary and hepatobiliary systems, but increases blood serum alkaline phosphatase activity. PEG-Filstim causes development of pronounced neutrophil leucocytosis and increase in monocyte, lymphocyte and eosinophil count. In the maximum dose of 2.0 mg/kg the studied drug decreases blood red cell count and haemoglobin level.
Authors and Affiliations
V. L. Karbovskyi, I. A. Shevchuk, O. V. Kurkina, T. Ye. Makovska
Keywords
Related Articles
- EP ID EP556024
- DOI 10.32352/0367-3057.2.17.10
- Views 58
- Downloads 0
Seamless access for the handicapped persons to pharmacy chain on principles of pharmaceutical law
The problem of access of citizens and patients with disabilities (wheelchair users) to the establishments of the pharmacy chain is relevant. The aim of the work was to examine the causes which prevent unimpeded access o...
Validation methods quantifying zopiclone tablets by HPLC
Zopiclone is a nonbenzodiazepine hypnotic agent used in the treatment of insomnia. It is a cyclopyrrolone, which increases the normal transmission of the neurotransmitter GABA in the central nervous system, as benzodiaze...
Cardiotropic action of combined use of celecoxib and amlodipine in rats sicked on adjuvant arthritis coupled with arterial hypertension
Drug therapy of rheumatoid arthritis combined with arterial hypertension is among actual medical objectives. The complexity of pharmacological treatment of comorbid state is due to not only pathological process severity,...
Organization of medical care for children in Ukraine (review of literature)
The realization of high quality medical measures for protecting children’s health remains an important issue at the stage of reforming the domestic medicine. The aim of this work was to study and analyze the system of me...
Identification and quantitative determination of the flavonoids of the complex dense extract of st. john's wort herb and pot marigold flowers
Common Saint-John's wort (Hypericum perforatum) and pot marigold (Calendula officinalis) are rich in such biologically active substances (BAS) as carotene, ascorbic acid, essential oils, vitamins, tannin and resinous sub...